How Pharmacy Benefit Managers (PBMs) Set the Price You Pay

Pharmacy benefit managers, or PBMs, are among the most powerful and least understood players in US healthcare. They rarely deal with patients directly, yet they heavily influence which drugs your plan covers and what you pay. This explainer demystifies what PBMs do and why they matter to your wallet.

The context here draws on public data from the Medicare Part D dashboard and CMS. PBMs are a key reason the same drug varies so much in price — the broader picture is in our guide on why prescriptions cost so much.

What a PBM actually does

• Negotiates prices and rebates with drug manufacturers.
• Builds the formulary — the list of covered drugs and their tiers.
• Sets pharmacy reimbursement and patient copay structures.
• Processes claims when you fill a prescription.

The rebate model

PBMs negotiate rebates from manufacturers in exchange for placing a drug on the formulary and at a favorable tier. Crucially, rebates are usually calculated as a percentage off the list price — which creates an incentive for high list prices, since a bigger list price can mean a bigger rebate. Those rebates flow to the PBM and plan, not always to the patient at the counter.

How this shapes your copay

Your copay is often based on the drug's list price, not the lower net price after rebates. That means you can pay a copay calculated off an inflated number, even though your plan is receiving a discount you never see. For uninsured patients, the effect is starker — they are closest to the full list price with no rebate benefit at all.

Concentration and opacity

A small number of large PBMs process the majority of US prescriptions, giving them significant leverage over manufacturers and pharmacies alike. Because the negotiated prices and rebates are confidential, patients cannot easily see whether they are getting a fair deal — which is precisely why an independent price comparison is valuable.

What you can do about it

You cannot negotiate with a PBM, but you can route around the opacity. Comparing the cash price against your copay often reveals that paying cash — or using a coupon or transparent pharmacy — is cheaper. Generic atorvastatin or lisinopril frequently cost less in cash than a formulary copay. See how GoodRx works, which resells PBM-negotiated cash rates.

Spread pricing and other hidden mechanics

Beyond rebates, PBMs have historically used practices that are invisible to patients but affect the overall cost of the system. One is spread pricing, where a PBM charges the health plan more for a drug than it reimburses the pharmacy and keeps the difference. Another is the network of fees and clawbacks levied on pharmacies, which can squeeze independent drugstores in particular. There have also been clauses that discouraged pharmacists from telling customers when paying cash would be cheaper than using insurance — so-called gag clauses, which federal law has since restricted. You do not need to master these mechanics, but knowing they exist explains why the price you see is the product of deals you never witness, and why the cash price and the insurance price can diverge in ways that seem to make no sense.

The takeaway is not that PBMs are villains or saints, but that the system they run is opaque by design. When the pricing is hidden, the only reliable defense available to an individual is to compare the concrete numbers you can actually see — your copay versus the cash price versus a coupon price — and choose the lowest.

How PBMs affect which drug you can get

PBMs influence not just price but access. The formulary they build determines which drugs your plan covers and at what tier, and it is also where tools like prior authorization and step therapy live — requirements that you try a cheaper drug first, or get special approval, before an expensive one is covered. These tools can steer you toward lower-cost options, which sometimes aligns with your interest, but they can also delay access to a drug your prescriber preferred. When a medication is not on your formulary or sits on a high tier, the cash price occasionally becomes the more practical route, especially for inexpensive generics that were never worth running through insurance in the first place. Understanding that the formulary is a PBM-shaped document, not a fixed medical fact, helps you ask the right questions when coverage is denied or a drug costs more than expected.

If you hit a formulary wall, your prescriber can often request an exception or point you to a covered alternative, and for cheap generics you can simply compare the cash price. The formulary is a negotiation outcome, and you have more room to work around it than it first appears.

How BetterBuyRx helps

BetterBuyRx sidesteps the PBM black box by showing verified cash prices across pharmacies and coupon networks, so you can compare them against your insurance copay and pick the lowest. We take no PBM or pharmacy commissions, so nothing about our ranking is shaped by rebate deals. Look up any drug like metformin to compare.